While primarily produced in the pineal gland, melatonin’s influence goes beyond its well-known role in regulating sleep, nighttime metabolism, and circadian rhythms, in the field of chronobiology. A plethora of new data demonstrates melatonin to be a very powerful molecule, being a potent ROS/RNS scavenger with anti-inflammatory, immunoregulatory, and oncostatic properties. Melatonin and its metabolites exert multiple beneficial effects in cutaneous and systemic aging. This review is focused on the neuroprotective role of melatonin during aging. Melatonin has an anti-aging capacity, retarding the rate of healthy brain aging and the development of age-related neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, etc. Melatonin, as well as its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), can reduce oxidative brain damage by shielding mitochondria from dysfunction during the aging process. Melatonin could also be implicated in the treatment of neurodegenerative conditions, by modifying their characteristic low-grade neuroinflammation. It can either prevent the initiation of inflammatory responses or attenuate the ongoing inflammation. Drawing on the current knowledge, this review discusses the potential benefits of melatonin supplementation in preventing and managing cognitive impairment and neurodegenerative diseases.
Thyroid hormones play an important role in the modeling of neural networks in the brain. Besides its metabolic effects, thyroid dysfunction, and hypothyroidism in particular, is frequently associated with cognitive decline and depressive-like behavior. The current study aimed to examine the changes in behavior, cognition, and memory in rats with propylthiouracil-induced overt hypothyroidism. The behavior and cognition were assessed using the open field test, T-maze, and novel object recognition test. We found significant differences in the behavioral patterns of the hypothyroid animals showing a reduction in locomotor activity, frequency of rearing, and impaired memory function compared to the euthyroid controls. As serotonin is an essential biomarker regulating cognition and mood, we tried to modulate the serotonin mediation in hypothyroid animals through tryptophan administration. Treatment with 5-hydroxy-tryptophan (5-OH-TRP) intraperitoneally for 10 days or directly into the hippocampus as a single injection led to attenuation of the hypothyroidism-induced cognitive and memory decline. A staggering amount of research is suggesting that the common denominators in the pathophysiology of depression and the behavior changes in hypothyroidism are the hippocampal complex and the distorted serotonin metabolism. In our study, it was observed a significant alleviation of cognitive impairment and an improvement of memory performance in hypothyroid rats after 5-OH-TRP administration. Current results are promising and may serve as groundwork for further investigation of functional and structural changes in the hippocampus during a hypothyroid state, and in particular, the effects of serotonin mediation in hypothyroid-associated depressive-like behavior.
The dysregulation of the kynurenine branch from tryptophan (TRP) metabolism can cause an imbalance between neuroprotective kynurenic acid and neurotoxic kynurenine metabolites in some psychiatric and neurodegenerative disorders. Therefore, the modulation of TRP metabolism may contribute to novel therapeutic strategies for several neuropsychiatric diseases. Targeting L-TRP-kynurenine pathway enzymes, particularly involving indoleamine 2,3-dioxygenase-1, tryptophan 2,3-dioxygenase, kynurenine 3-monooxygenase, and kynurenine aminotransferase II, is a promising approach. The future development of potent selective inhibitors of these enzymes with a good safety profile would be a potential new avenue for the treatment of many diseases. The essential amino acid L-Tryptophan, together with its metabolites, plays a key role in diverse physiological and pathophysiological processes in the brain, especially in neurodegenerative and psychiatric disorders and autoimmunity. Also, TRP is a vital biochemical precursor for several functional neuroactive molecules, including serotonin and melatonin, which are of great importance for memory and learning, emotional regulation, circadian cycle, hunger, pain, etc. This article aims to underscore the links between tryptophan’s metabolism and certain diseases of the central nervous system.
High-frequency immersed plasma discharge represents an efficient method for the generation of reactive oxygen and nitrogen species (RONS) in liquid media, leading to complex redox and oxidative processes in biologically relevant systems. Although plasma-generated reactive species in liquids have been widely investigated, it remains insufficiently understood how working-gas-dependent plasma chemistry translates into oxidative outcomes in iron-containing model systems, where plasma-derived species may interact with transition-metal redox cycling. The novelty of this study lies in the combined assessment of gas-dependent RONS accumulation, deoxyribose oxidative degradation, and plasma-induced changes in Fe(II) availability using a high-frequency immersed plasma discharge. Herein, we examined whether treatment with high-frequency immersed discharge influences the redox state of iron in a working gas-dependent manner, thereby affecting oxidative degradation in the deoxyribose model. Plasma treatment was performed under air and argon working gas conditions, and oxidative degradation was evaluated using the thiobarbituric acid reactive substances (TBA-RS) assay. In parallel, the concentrations of long-lived reactive species, including hydrogen peroxide, nitrites, and nitrates, were determined spectrophotometrically. The results demonstrated a treatment-time-dependent increase in oxidative degradation and reactive species accumulation, with more pronounced oxidative effects observed under argon plasma conditions. In the presence of ferrous ions, plasma treatment resulted in a gas-dependent effect, characterized by a synergistic enhancement of oxidative degradation under argon and a biphasic effect under air. Most notably, in Fe(II)-containing samples, 10 min of argon plasma treatment increased TBA-RS formation to approximately 2.7-fold of the Fe(II) control, whereas air plasma produced a biphasic response, with an initial decrease followed by an approximately 40% increase at the longest exposure time. Additional experiments suggest that plasma may influence the redox state and availability of ferrous ions, thereby affecting their participation in Fenton-type reactions and radical-mediated processes. The findings suggest that the overall oxidative outcome in plasma-treated systems is governed not only by the concentration of plasma-generated reactive species but also by plasma-induced modifications of transition metal redox chemistry. These preliminary results on the combined roles of plasma-generated reactive species and transition-metal chemistry contribute to understanding plasma–liquid interactions in such systems.